tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

SCYNEXIS Inc

SCYX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
3.210USD
-0.120-3.60%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
31.94M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

SCYNEXIS Inc ์ •๋ณด ํšŒ์‚ฌ

SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It is developing its antifungal platform fungerps, a class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have shown in vitro and in vivo activity against a range of human fungal pathogens such as Candida and Aspergillus genera, including multidrug-resistant strains, as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and common mucorales species. Ibrexafungerp is the first representative of this class of antifungals with additional assets from the fungerp family under development, including SCY-247, which is in clinical stages of development. The United States Food and Drug Administration approved BREXAFEMME (ibrexafungerp tablets) for treatment of patients with vulvovaginal candidiasis, and for the reduction in the incidence of recurrent vulvovaginal candidiasis.

SCYNEXIS Inc ํ”„๋กœํ•„

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ SCYX
ํšŒ์‚ฌ ์ด๋ฆ„SCYNEXIS Inc
์ƒ์žฅ์ผMay 02, 2014
CEOAngulo (David)
์ง์› ์ˆ˜28
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒMay 02
์ฃผ์†Œ1 Evertrust Plaza
๋„์‹œJERSEY CITY
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ07302-6548
์ „ํ™”12018845485
์›น์‚ฌ์ดํŠธhttps://www.scynexis.com/
์ข…๋ชฉ ์ฝ”๋“œ SCYX
์ƒ์žฅ์ผMay 02, 2014
CEOAngulo (David)

SCYNEXIS Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
20.39K
-23.36%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
9.75K
+29.49%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
9.75K
+29.49%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
9.75K
+29.49%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
8.88K
+32.39%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
8.88K
+32.39%
Mr. Armando Anido
Mr. Armando Anido
Independent Director
Independent Director
8.88K
+32.39%
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Scott A. Sukenick, J.D.
Mr. Scott A. Sukenick, J.D.
Chief Legal Officer, General Counsel
Chief Legal Officer, General Counsel
40.31K
+2.14%
Mr. Ivor Macleod, CPA
Mr. Ivor Macleod, CPA
Chief Financial Officer
Chief Financial Officer
20.39K
-23.36%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
9.75K
+29.49%
Mr. Guy Macdonald
Mr. Guy Macdonald
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
9.75K
+29.49%

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

SCYNEXIS Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
SCYNEXIS Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค: Mr. Scott A. Sukenick, J.D.

SCYNEXIS Inc(SCYX)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2026Q1 ๊ธฐ์ค€์œผ๋กœ, SCYNEXIS Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 102๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 20.05M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 25.24%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q4 ๋Œ€๋น„ 6876363.00 ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ